Abstract
The first antagonists known for the histamine H3 receptor were mono-substituted imidazolecontaining compounds like thioperamide. Meanwhile numerous novel leads have been developed possessing improved affinities, selectivities, specificities, and pharmacokinetic properties. Scope and limitations of this promising class are discussed concerning their structure-activity relationships as well as pharmacological and potential therapeutic aspects.
Keywords: cipralisant, ciproxifan, clobenpropit, h3 receptor, imidazole, sch 79687, radioligand, thioperamide
Mini-Reviews in Medicinal Chemistry
Title: Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists
Volume: 4 Issue: 9
Author(s): Holger Stark, Markus Kathmann, Eberhard Schlicker, Walter Schunack, Birgit Schlegel and Wolfgang Sippl
Affiliation:
Keywords: cipralisant, ciproxifan, clobenpropit, h3 receptor, imidazole, sch 79687, radioligand, thioperamide
Abstract: The first antagonists known for the histamine H3 receptor were mono-substituted imidazolecontaining compounds like thioperamide. Meanwhile numerous novel leads have been developed possessing improved affinities, selectivities, specificities, and pharmacokinetic properties. Scope and limitations of this promising class are discussed concerning their structure-activity relationships as well as pharmacological and potential therapeutic aspects.
Export Options
About this article
Cite this article as:
Stark Holger, Kathmann Markus, Schlicker Eberhard, Schunack Walter, Schlegel Birgit and Sippl Wolfgang, Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists, Mini-Reviews in Medicinal Chemistry 2004; 4 (9) . https://dx.doi.org/10.2174/1389557043403107
DOI https://dx.doi.org/10.2174/1389557043403107 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway
Current Alzheimer Research Microwave Assisted Amination of 2-Chloro Azoles with Various Substituted Aryl Piperazines and Aryl Sulfonylpiperazines Under Neat Conditions
Current Microwave Chemistry Pharmacological Applications of Antioxidants: Lights and Shadows
Current Drug Targets Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model
Current Alzheimer Research Immunotherapy for Multiple Sclerosis: Basic Insights for New Clinical Strategies
Current Neurovascular Research Genetic Polymorphisms Might Predict Suicide Attempts in Mental Disorder Patients: A Systematic Review And Meta-Analysis
CNS & Neurological Disorders - Drug Targets Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?
Current Pharmaceutical Design A Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Current Alzheimer Research Novel Opioid Receptor Agonists with Reduced Morphine-like Side Effects
Mini-Reviews in Medicinal Chemistry Drug Likeness and Selective Functionalization of Quinoxalines
Current Organic Synthesis Effect of Polyherbal Drug Majun Falasfa on the Transgenic Drosophila Model of Parkinson’s Disease
Current Traditional Medicine Chitin Synthesis as a Target for Antifungal Drugs
Current Drug Targets - Infectious Disorders Regulatory T-Cells: Immunomodulators in Health and Disease
Current Topics in Medicinal Chemistry Vitamin D and the Metabolic Syndrome
Current Vascular Pharmacology TGF-β Pathway as a Potential Target in Neurodegeneration and Alzheimers
Current Alzheimer Research Ovarian Toxicity: From Environmental Exposure to Chemotherapy
Current Pharmaceutical Design Construction of an M1GS Ribozyme for Targeted and Rapid mRNA Cleavage; Application on the Ets-2 Oncogene
Medicinal Chemistry Pharmacologic Overview of Chlorogenic Acid and its Metabolites in Chronic Pain and Inflammation
Current Neuropharmacology Neuroproteomics: Are We Biased in Our Representation of Molecular Targets Associated with Specific Domains? Implications in Biomarker Discovery
Current Proteomics Disposition of Drugs of Abuse and Their Metabolites in Wastewater as a Method of the Estimation of Drug Consumption
Current Drug Metabolism